Revised code to increase investor confidence: promote it on your website


Thursday, 05 December, 2013

Biotechnology companies are urged to display their adherence to the ‘Code of Best Practice for Reporting by Life Science Companies’ on the company website - either on the front page or on the investor relations landing page.

The code has recently been revised and updated in consultation with the ASX and industry experts. An online endorsement ‘button’ for the use of companies that have implemented the code is available free of charge to indicate to investors that the company seeks to disclose according to best practice in accordance with the code, thus giving investors assurance in the life science business.

The code aims to support the directors and management of Australian ASX-listed life science companies to adopt international best practice in reporting events to investors. It also seeks to provide investors with a level of confidence through providing guidance on disclosure and appropriate reporting, as well as educational support regarding clinical trials and other matters.

More information can be found at www.ausbiotech.org/biotechboards.

Related News

Abnormal brain protein targeted in Parkinson's study

Researchers have identified a new brain protein involved in the development of Parkinson's...

Epilepsy disease model treated in a laboratory dish

A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...

Newborns have elevated levels of an Alzheimer's biomarker

What do the brains of newborns and patients with Alzheimer's disease have in common? Both...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd